Cargando…
A High-Dose Cortisol Receptor Antagonist for the Management of Severe Hyperglycemia in a Patient With an Adrenocortical Carcinoma
The management of functional adrenocortical carcinoma (ACC) is challenging as it involves treating the underlying endocrinological abnormalities such as hypercortisolism. Competitive glucocorticoid receptor antagonist such as mifepristone (Korlym(®)) can be used to treat dysglycemia secondary to hyp...
Autores principales: | Merino, Hilda, Luna, Nancy Torres, Paniagua, Gabriela Zuniga, Yau, Hanford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089267/ http://dx.doi.org/10.1210/jendso/bvab048.207 |
Ejemplares similares
-
OR03-04 The Study of Cell Senescence in Cortisol-Producing Adrenocortical Adenomas
por: Gao, Xin, et al.
Publicado: (2020) -
Atypical Adrenocortical Incidentaloma Causing Autonomous Cortisol Secretion and Cardiovascular Complications
por: Gaballa, Salem, et al.
Publicado: (2021) -
Selective Serotonin Reuptake Inhibitors Increase Urinary Free Cortisol in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease
por: Chrysavgi Kamilaris, Crystal Dawn, et al.
Publicado: (2021) -
SUN-356 The Effects of Selective Serotonin Reuptake Inhibitors on Urinary Free Cortisol in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease
por: Kamilaris, Crystal, et al.
Publicado: (2019) -
SUN-190 Metastatic Adrenocortical Carcinoma in Remission After a Single Dose of Gemcitabine
por: Go, Muriel Tania L, et al.
Publicado: (2020)